Literature DB >> 9720640

Valuing temporary and chronic health states associated with breast screening.

K Johnston1, J Brown, K Gerard, M O'Hanlon, A Morton.   

Abstract

The aim of this study was to derive quality of life values for the four key breast screening outcomes (true negative, false positive, true positive and false negative), including the quality of life effects of the screening and treatment processes. In doing so, methodological issues in health status measurement were explored, in particular the valuation of temporary health states. The true negative and false positive descriptions were temporary health states, lasting for short term durations (12 months) and the true positive and false negative outcomes were chronic health states lasting for long term durations (rest of life). Descriptions of breast screening outcomes were valued using the time trade-off technique and the visual analogue scale. Paired comparisons between TTO values for states with the same duration found a difference between the true negative and the false positive time trade-off values but no difference for true positive and false negative descriptions. The TTO values for the false positive were low. The study highlights several important methodological issues such as the use of the two stage procedure for valuing temporary health states, the impact of duration on values, the impact of anchor points, and the importance of qualitative analysis of respondents values. Further empirical testing of all these issues is recommended.

Entities:  

Mesh:

Year:  1998        PMID: 9720640     DOI: 10.1016/s0277-9536(98)00065-3

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  13 in total

1.  Health economic evaluation.

Authors:  A Shiell; C Donaldson; C Mitton; G Currie
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

2.  The cost-utility of magnetic resonance imaging for breast cancer in BRCA1 mutation carriers aged 30-49.

Authors:  Richard P A Norman; D Gareth Evans; Douglas F Easton; Kenneth C Young
Journal:  Eur J Health Econ       Date:  2007-03-09

3.  Utilities and disutilities for attributes of injectable treatments for type 2 diabetes.

Authors:  Kristina S Boye; Louis S Matza; Kimberly N Walter; Kate Van Brunt; Andrew C Palsgrove; Aodan Tynan
Journal:  Eur J Health Econ       Date:  2010-03-12

4.  Assessment of health state utilities for attention-deficit/hyperactivity disorder in children using parent proxy report.

Authors:  Louis S Matza; Kristina Secnik; Anne M Rentz; Sally Mannix; F Randy Sallee; Donald Gilbert; Dennis A Revicki
Journal:  Qual Life Res       Date:  2005-04       Impact factor: 4.147

5.  Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysis.

Authors:  Rahber Thariani; Norah Lynn Henry; Scott D Ramsey; David K Blough; Bill Barlow; Julie R Gralow; David L Veenstra
Journal:  J Comp Eff Res       Date:  2013-05       Impact factor: 1.744

Review 6.  Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children: theoretical and methodological considerations.

Authors:  Lisa A Prosser; James K Hammitt; Ron Keren
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

7.  Quality of life valuations of mammography screening.

Authors:  Amy E Bonomi; Denise M Boudreau; Paul A Fishman; Evette Ludman; Amy Mohelnitzky; Elizabeth A Cannon; Deb Seger
Journal:  Qual Life Res       Date:  2008-05-20       Impact factor: 4.147

8.  Utilities and disutilities for type 2 diabetes treatment-related attributes.

Authors:  Louis S Matza; Kristina S Boye; Nicole Yurgin; Jessica Brewster-Jordan; Sally Mannix; Jodi M Shorr; Beth L Barber
Journal:  Qual Life Res       Date:  2007-07-19       Impact factor: 4.147

9.  Construct validity of the interview time trade-off and computer time trade-off in patients with rheumatoid arthritis: a cross-sectional observational pilot study.

Authors:  Laurien Buitinga; Louise Ma Braakman-Jansen; Erik Taal; Mart Afj van de Laar
Journal:  BMC Musculoskelet Disord       Date:  2012-06-25       Impact factor: 2.362

10.  Health-state valuations for pertussis: methods for valuing short-term health states.

Authors:  Grace M Lee; Joshua A Salomon; Charles W LeBaron; Tracy A Lieu
Journal:  Health Qual Life Outcomes       Date:  2005-03-21       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.